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“Prion-like propagation” has recently been proposed for disease spread in Cu/Zn superoxide
dismutase 1 (SOD1)-linked familial amyotrophic lateral sclerosis (ALS). Pathological SOD1
conformers are presumed to propagate via cell-to-cell transmission. In this model, the risk-
based kinetics of neuronal cell loss over time appears to be represented by a sigmoidal
function that reﬂects the kinetics of intercellular transmission. Here, we describe an alter-
native view of prion-like propagation in SOD1-linked ALS – its relation to disease prognosis
under the protective-aggregation hypothesis. Nucleation-dependent polymerization has
been widely accepted as the molecular mechanism of prion propagation. If toxic species
of misfolded SOD1, as soluble oligomers, are formed as on-pathway intermediates of
nucleation-dependent polymerization, further ﬁbril extension via sequential addition of
monomeric mutant SOD1 would be protective against neurodegeneration.This is because
the concentration of unfolded mutant SOD1 monomers, which serve as precursor of
nucleation and toxic species of mutant SOD1, would decline in proportion to the extent of
aggregation. The nucleation process requires that native conformers exist in an unfolded
state that may result from escaping the cellular protein quality control machinery. However,
prion-like propagation-SOD1 aggregated form self-propagates by imposing its altered
conformation on normal SOD1-appears to antagonize the protective role of aggregate
growth.The cross-seeding reaction with normal SOD1 would lead to a failure to reduce the
concentration of unfolded mutant SOD1 monomers, resulting in continuous nucleation
and subsequent generation of toxic species, and inﬂuence disease prognosis. In this
alternative view, the kinetics of neuronal loss appears to be represented by an exponential
function, with decreasing risk reﬂecting the protective role of aggregate and the potential
for cross-seeding reactions between mutant SOD1 and normal SOD1.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neu-
rodegenerative disease affecting motor neurons for which there
is no effective treatment. The average disease duration is about
3 years, but it can vary signiﬁcantly. Death usually results from
compromised function of respiratory muscles. Since the land-
mark discovery in 1993 that mutations in the Cu/Zn superoxide
dismutase 1 (SOD1) gene cause the familial form of ALS (FALS;
Rosen et al., 1993), the underlying molecular features, and associ-
ated clinical characteristics of this disease have been extensively
annotated. More than 150 different mutations of SOD1 have
been found in patients with familial ALS. Studies on the clinical
course of FALS suggest that the duration of illness is rela-
tively consistent for each SOD1 mutation, but variable among
the different mutations; for example, patients with the A4V
mutation survive an average of 1 year after diagnosis, whereas
patients with the H46R mutation survive an average of 18 years
(Czaplinski et al., 2006). Aggregation of misfolded SOD1 pro-
teins is a common pathological ﬁnding among subjects with
different SOD1 mutations and is therefore believed to be cen-
tral to disease pathogenesis (Johnston et al., 2000; Kato et al., 2001;
Wang et al., 2003). The severity of mutant-induced destabilizing
effects on the SOD1 molecule appears to correlate weakly with
disease progression (Lindberg et al., 2005; Sato et al., 2005). How-
ever, the molecular mechanisms underlying variations in age of
onset and disease duration of these conditions remain largely
unknown.
Using ALS models derived from human embryonic stem cells
or transgenic mice, recent studies have demonstrated that both
cell-autonomous and non-cell-autonomous processes contribute
to neurodegeneration in SOD1-linked FALS (Nagai et al., 2007;
Di Giorgio et al., 2007; Yamanaka et al., 2008; Wada et al., 2012).
Mutant SOD1 overexpression in differentiated motor neurons is
sufﬁcient to induce selective cell death and formation of aggre-
gates as inclusions that mimic the in vivo human ALS disease.
Furthermore, neuronal losses are enhanced when motor neu-
rons are co-cultured with astrocytes expressing mutant SOD1
(Nagai et al., 2007; Di Giorgio et al., 2007). Clinically, the rela-
tionship between mean age at onset and mean survival time
among patients with different SOD1 mutations are poorly cor-
related (Sato et al., 2005; Wang et al., 2008). These ﬁndings suggest
differences in the mechanisms responsible for the initiation and
progression of the neurodegenerative process in SOD1-linked
FALS.
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Prion disorders, such as Creutzfeldt-Jakob disease, are infec-
tious diseases caused by the amyloid form of the prion protein,
PrPSc, which endlessly self-propagates by imposing its altered con-
formation on the cellular prion protein, PrPC (Prusiner, 1998).
We use the term “prion-like propagation” to describe this molec-
ular event—self-templating replication to cross-seed aggregation
of normal cellular counterparts. Recent studies have suggested
prion-like propagation as a mechanistic model of lesion spread
in SOD1-linked FALS (Grad et al., 2011; Munch et al., 2011;
Polymenidou and Cleveland, 2011; Grad and Cashman, 2014).
Although there has been no evidence of transmission of SOD1
aggregates between individuals, using cultured neuronal cells,
mutant SOD1 aggregates showed prion-like behavior, a process
involving a cross-seed aggregation of normal SOD1 and cell-to-
cell transmission of misfolded SOD1 aggregates (Grad et al., 2011,
2014; Munch et al., 2011). Neurodegeneration in ALS typically
begins focally and then spreads spatiotemporally until motor neu-
rons of the respiratory system are lost (Ravits et al., 2007a,b). An
attractive model for this progression would be the spread of toxic
aggregates from a focal site through cell-to-cell transmission.
Aggregation of misfolded proteins is a pathological hallmark of
many neurodegenerative diseases and is generally considered to be
controlled by nucleation-dependent polymerization—a two stage
processes consisting of the energetically unfavorable formation of
a nucleus (i.e., nucleation), followed by efﬁcient elongation of that
nucleus via sequential addition of monomers. There is a major
controversy concerning the role of aggregates growth in disease
pathogenesis. One hypothesis is that these aggregates play a vital
role in both disease initiation and progression, with the misfolded
versions of endogenous proteins likely to acquire toxic properties,
potentially through increased hydrophobicity and/or sequestra-
tion of essential cellular components within the aggregates and
other pathways. An alternative hypothesis is that the large aggre-
gates represent not the toxic species but rather the ﬁnal product
of a defensive response aimed at protecting cells from more toxic
oligomeric species.
Under the assumption that toxic species of misfolded SOD1,
as soluble oligomers, are formed as on-pathway intermediates
of nucleation-dependent polymerization, we describe here an
alternative view of prion-like propagation in SOD1-related ALS
mechanism. These different notions reﬂect uncertainties sur-
rounding the roles of misfolded protein aggregates (toxic versus
protective). In this alternative view, the ability of the aggregated
form of SOD1 to cross-seed aggregate normal SOD1 appears to
antagonize the protective role of aggregate growth. Thus, prion-
like propagation would be expected to exert a signiﬁcant inﬂuence
on disease prognosis. On the basis of available data for SOD1-
linked FALS, together with a risk-based modeling approach, we
show that prion-like propagation may account for up to 84% of
the variability in survival times among subjects with different
SOD1 mutations, highlighting the prognostic value of prion-
like propagation and providing potential therapeutic targets for
SOD1-linked FALS.
PRION-LIKE PROPAGATION IN SOD1-LINKED FALS
Two essential steps are required for prion infectivity: self-
templating replication and an efﬁcient replication cycle (Cushman
et al., 2010). For efﬁcient infectivity, pathogenic prion proteins
overwhelm the ﬁrst key step of self-templating replication by
converting the α-helix-rich host-encoded PrPC into PrPSc, char-
acterized by a higher β-sheet content and a polymeric state
(Figure 1A; Prusiner, 1998; Jackson et al., 1999). This process
is thought to be achieved by a nucleation-dependent polymer-
ization mechanism. Typically, this capture and conversion process
requires that native conformers exist in a transiently unfolded state
or possess an intrinsically unfolded domain. The second step is
associated with frangibility of the ﬁbril structure. Ampliﬁcation
of conformational replication is achieved by the fragmentation
of amyloid forms to liberate new ﬁber ends where prion replica-
tion occurs. Increased frangibility leads to more ﬁber ends per
unit mass and, consequently, more rapid conversion of avail-
able monomers (Figure 1B; Tanaka et al., 2006; Colby et al.,
2009).
Cu/Zn superoxide dismutase 1 aggregated form could also
seed misfolding of a much larger amount of wild-type (WT)
SOD1 in vitro (Chia et al., 2010). Moreover, in cultured cells,
FIGURE 1 | Prion propagation based on nucleation-dependent
polymerization.Two events are essential for infectivity: (A) conversion of
the α-helix-rich, host-encoded prion protein (PrPC) into a pathogenic
conformer (PrPSc), characterized by a higher β-sheet content and a
polymeric state, through a nucleation-dependent polymerization
mechanism; and (B) fragmentation of the PrPSc amyloid conformer to
liberate new ﬁbril ends that are the sites of the conversion of PrPC into
PrPSc, leading to ampliﬁcation of conformational replication. (C) Schematic
illustration of the kinetics of infected cells over time.
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SOD1 aggregated forms, either exogenously applied (Munch
et al., 2011; Grad et al., 2014) or formed within cells (Grad et al.,
2011), induced the misfolding and subsequent aggregation of the
respective native proteins. Importantly, induced aggregation of
endogenous SOD1 was shown to persist after removal of the mis-
folded seeds, suggesting that the newly formed aggregates could
act as templates for the subsequent misfolding of additional native
SOD1 (Grad et al., 2011, 2014; Munch et al., 2011). Although frag-
mentation of the SOD1 aggregated forms to liberate new ﬁber
ends has not yet been veriﬁed, these behaviors are consistent with a
self-perpetuating, cyclic reaction, analogous to that underlying the
replication of infectious prion aggregates. These ﬁndings raise the
possibility that SOD1-linked ALS progresses through the spread
of toxic SOD1 aggregates from a focal site in a manner similar
to that of prion spread (cell-to-cell transmission of pathological
misfolded prions). However, studies of SOD1 have found no evi-
dence that directly links the transmission of SOD1 aggregates to
neuronal toxicity.
Work over the past 4 years indicates that multiple proteins
associated with neurodegenerative diseases, especially tau and
α-synuclein can propagate aggregates between cells in a prion-like
manner. Frost et al. (2009) demonstrated, for the ﬁrst time, that
aggregates of tau protein were taken up into cultured cells where
they could induce ﬁbrillization of intracellular tau (Guo and Lee,
2011). Further, tau aggregates newly formed in a cell were observed
to transfer to co-cultured cells (Frost et al., 2009). This work was
subsequently replicated for α-synuclein (Desplats et al., 2009; Luk
et al., 2009; Lee et al., 2010; Hansen et al., 2011; Volpicelli-Daley
et al., 2011; Freundt et al., 2012) and SOD1(Munch et al., 2011). It
is now well established that protein aggregates are mobile, and can
transmit aggregates from cell to cell in vitro.
KINETICS OF NEURONAL CELL LOSS
In the model of prion-like propagation in SOD1-linked FALS
(cell-to-cell transmission of pathological SOD1 conformers), it
is predicted that the kinetics of neuronal cell death over time
can be expressed by a sigmoidal function that reﬂects the kinet-
ics of intercellular transmission over time (Figure 1C). If one
amyloid conformer of a disease-speciﬁc protein liberates three
particles that can penetrate a cell, then after ﬁbril growth, the
next fragmentation would yield nine particles. Thus, the risk of
intercellular transmission would be accelerated in early and mid-
dle stages of the disease through fragmentation of the amyloid
conformer, but the efﬁciency of transmission would decline in the
advanced stage.
AN ALTERNATIVE VIEW OF PRION-LIKE PROPAGATION IN
SOD1-LINKED FALS
Under the assumption that toxic species of disease-speciﬁc pro-
teins, for example as soluble oligomers, are formed as on-pathway
intermediates of ﬁbril growth through nucleation-dependent
polymerization, further ﬁbril extension would be protective
against neurodegeneration. According to the free energy pro-
ﬁle as a function of aggregate size, free energy peaks at the
nucleus stage, and decreases in proportion to the extent of growth
of aggregates (Oosawa and Kasai, 1962). Thus, toxic species
of misfolded proteins are expected to be structurally stabilized.
Importantly, an additional protective effect of aggregate growth is
to reduce the concentrationof theunfolded/misfoldedmonomeric
proteins. These species of disease-speciﬁc proteins are consid-
ered to serve as precursors of nucleation—a critical stage in
the assembly of a polymeric structure. The ﬁbril nucleation
rate is determined as an explicit function of the concentra-
tion of the protein solution (Ferrone, 1999). The rate constants
for nucleation, estimated by non-linear least-squares algorithms,
are ∼10,000,000 times smaller than those for ﬁbril growth (Lee
et al., 2007). A reduction in the corresponding protein concentra-
tion inhibits the nucleation process and subsequent generation
of the toxic species of disease-speciﬁc proteins in the affected
cells.
In contrast to prion-like propagation in disease spread, we
present an alternative view of prion-like propagation in the con-
text of the protective-aggregation hypothesis in which SOD1 toxic
species are formed as an on-pathway intermediate in nucleation-
dependent polymerization. Although the cross-seeding reaction
of prion-like propagation seems to have little inﬂuence on the sta-
bilizing effect of ﬁbril growth on the toxic species of misfolded
SOD1, it can be predicted to antagonize the protective role of
aggregate growth.
Instead of cell-to-cell transmission of the pathological SOD1
conformer, the endogenous, stochastic occurrence of mutant
SOD1 nucleation in neuronal cells plays a pivotal role in dis-
ease initiation and spread. The subsequent generation of toxic
species of SOD1 then causes damage to the cells. In the affected
cells, however, further aggregate growth decreases the probability
of the next generation of nucleation by reducing the concentra-
tion of unfolded mutant SOD1 monomers into the ﬁbril under
the protective-aggregation hypothesis (Figure 2A). This species
of SOD1 is considered to serve as a precursor of nucleation and
subsequent toxic species (Furukawa et al., 2004; Hough et al.,
2004; Schmidlin et al., 2009). However, if the SOD1 aggregated
form preferentially self-propagates by cross-seeding aggregates
of normal SOD1 monomers; the result would be a failure to
reduce the concentration of unfolded mutant SOD1 monomers,
leading to continuous nucleation and the generation of toxic
species in the affected cells (Figure 2B). Thus, it is assumed
that the ability of the reaction underlying prion-like propaga-
tion to cross-seed normal SOD1 exerts a signiﬁcant inﬂuence
on disease prognosis. The concentration of unfolded mutant
SOD1 monomers varies according to the degree of the cross-
seeding reaction between the SOD1 aggregated form and normal
SOD1, altering nucleation probability and the generation of toxic
species.
KINETICS OF NEURONAL CELL LOSS
A simple analytical theory has been proposed to account for the lag
time distribution for a stochastic nucleated polymerization reac-
tion in which the lag time of nucleation probability versus the
number of unaffected cells ﬁts an exponential distribution (Szabo,
1988). Consistent with this exponential decay in the number of
unaffected cells, Colby et al. (2006) showed that, in cultured stri-
atal neurons expressing the mutant Huntington’s disease (HD)
protein, the probability of a cell remaining aggregate-free dropped
exponentially with time.
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FIGURE 2 | Prognostic role of prion-like propagation in SOD1-linked
FALS. Under the assumption that toxic species of misfolded SOD1 are
formed via on-pathway nucleation-dependent polymerization, prion-like
propagation antagonizes the protective role of aggregate growth. Small
oligomeric forms may be toxic, but for the sake of simplicity, the toxic species
are shown as tetramers in this schema. The number of monomeric units
involved in the formation of the nucleus for SOD1 aggregation is still
unknown, but shown as a dimer in this schema. (A) SOD1 aggregate growth
decreases the probability of the next generation of nucleation and formation
of toxic species by reducing the concentration of unfolded mutant SOD1
monomers in the affected cells (protective role of aggregate growth). (B)The
ability of the SOD1 aggregated form to cross-seed with normal SOD1 results
in a failure to reduce the concentration of unfolded mutant SOD1 monomers,
leading to continuous nucleation and the subsequent generation of toxic
species (prognostic role of prion-like propagation). (C) Under the assumption
of constant risk for neuronal cell damage, the kinetics of neuronal loss
(proportion of intact neurons as a function of time) shows a ﬁrst-order
exponential function (left panel). The kinetics of cell death shows an
exponential function with decreasing risk, with further elongation of
aggregates reducing the risk of cell death in proportion to the extent of the
increase in aggregate size (middle panel). The signiﬁcant inﬂuence of
prion-like propagation on disease prognosis through cross-seed aggregation
of normal SOD1 would closely ﬁt the exponential function indicated by the
gray arrow (right panel).
If soluble oligomers implicated in the toxicity of several neu-
rodegenerative disorders are formed via on-pathway nucleation-
dependent polymerization, the probability of nucleation would
be considered to pose a constant risk for cell death regardless
of its toxicity (Perutz and Windle, 2001; Sugaya and Matsubara,
2009). Nucleation is a rare event that occurs randomly in time and
space, and is a rate-limiting process with a thermodynamically
unfavorable state (Perutz and Windle, 2001). In a constant-risk
model of neurodegeneration, the death of a neuron is initiated
randomly in time by a series of single, rare catastrophic events,
and the death of any given cell is independent of that of any other
cell (Clarke et al., 2000). Under the constant-risk assumption, the
kinetics of neuronal loss over time exhibits an exponential func-
tion (Figure 2C, left panel; Clarke et al., 2000). Accordingly, the
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kinetics of cell death would be expected to show an exponential
function, with risk decreasing as further elongation of aggre-
gates reduced the generation of toxic, soluble oligomers; thus,
risk would decrease in proportion to the extent to which aggre-
gation increased (Figure 2C, middle panel). Under the scenario
of the failure to reduce the concentration of unfolded mutant
SOD1 monomers by cross-seeding aggregates of normal SOD1
monomers, we would expect the kinetics of cell death to closely ﬁt
an exponential function, but in the opposite direction (Figure 2C,
right panel).
ASSOCIATION WITH CLINICAL FINDINGS
A motor pool refers to all of the individual motor neurons that
innervate a single muscle. Because of motor pools in the spinal
cord are clustered in distinct columns of motor neurons extend-
ing over multiple spinal cord segments, a longitudinal study for
estimating the number of motor units from individual muscles in
ALS patients may provide a mechanistic insight into local disease
spread. A number of techniques have been developed to estimate
the number of motor units in humans by deﬁning a motor unit
as the spinal motor neuron and its axon together with the muscle
ﬁbers it innervates. Motor unit number estimation (MUNE) is a
technique that uses EMG to estimate the number of motor units in
a muscle. Using the most reliable electrophysiological method for
MUNE, the exponential nature of lower motor neuron loss over
time in both ALS patients and SOD1-linked FALS patients has
recently been demonstrated in all of the muscles examined (Bau-
mann et al., 2010, 2012). Furthermore, MUNE values obtained
with the Bayesian method show a solid correlation with the actual
number of lower motor neurons in the spinal cord, determined by
histology (Ngo et al., 2012). The exponential kinetics of neuronal
cell loss is consistent with the “one-hit” model of neurodegen-
eration described by Clarke et al. (2000). Thus, the endogenous,
stochastic occurrence of one-hit events in a homogenous popula-
tion of lower motor neurons may play a pivotal role in local disease
spread. The alternative view of prion-like propagation in the con-
text of the protective-aggregation hypothesis may well explain the
exponential nature of lower motor neuron loss in SOD1-linked
FALS.
ASSOCIATION WITH TRANSGENIC MOUSE MODEL
Further evidence to support the prognostic role of prion-like prop-
agation has come from co-expression studies using transgenic
mice. Since most familial ALS patients with SOD1 mutations
are heterozygous, recent studies have utilized transgenic mice
expressing both human WT (hWT) and ALS-related mutant
SOD1 to more accurately recapitulate SOD1 behavior in vivo.
Co-expression of SOD1hWT exacerbates the disease phenotypes
of SOD1G93A (Jaarsma et al., 2000; Fukada et al., 2001), SOD1G85R
(Wang et al., 2009), and SOD1A4V mice (Deng et al., 2006), hasten-
ing the appearance of cellular pathologies and shortening survival
times. The effect of the WT protein on SOD1A4V mice is par-
ticularly dramatic; even though ALS patients with this mutation
exhibit particularly rapid disease progression, mice expressing
SOD1A4V alone do not develop motor neuron disease within
their lifetimes (Gurney et al., 1994; Jaarsma et al., 2000). The
alternative view of prion-like propagation suggests that normal
SOD1 prevents the reduction in the concentration of mutant
SOD1 monomers, with a predicted shorter survival (Figure 2).
Indeed, the concentration of monomeric G93A-SOD1 protein is
markedly elevated in the tissues of transgenic mice carrying both
G93A-SOD1 andhWT-SOD1genes (G93A/hWT-mice) compared
to that in G93A-mice (Fukada et al., 2001). Furthermore, in
the affected tissue, SOD1 aggregates containing both WT and
mutant protein have been observed (Deng et al., 2006; Wang et al.,
2009), suggesting that hWT-SOD1 is “recruited” into non-native
oligomers by the mutant SOD1, possibly by the cross-seeding
reaction.
GENOTYPE–PHENOTYPE CORRELATIONS IN SOD1-LINKED
FALS UNDER THE PROTECTIVE-AGGREGATION HYPOTHESIS
The nucleation aggregation theory predicts that the probability of
nucleation is an exponential function of the free energy of nuclear
formation (Perutz and Windle, 2001). In the case of HD caused by
the expansion of CAG trinucleotide repeats, which creates proteins
containing long, toxic polyglutamine repeats, the change in free
energy per additional glutamine repeat is expected to be constant
(Perutz et al., 2002). Therefore, the probability of nucleation is
expected to rise exponentially with the number of repeats. This
appears to be reﬂected by the exponential relationship between the
extent of expansion and age of onset in HD (Perutz and Windle,
2001; Sugaya et al., 2007; Sugaya and Matsubara, 2009). In the
case of SOD1, a thermodynamic analysis suggests that the WT
protein is a so-called three-state dimer in which the individual
monomers also adopt their correct folded structures in the absence
of an intermolecular interface or stabilizing Zn and Cu ions (Banci
et al., 1998; Stroppolo et al., 2000; Strange et al., 2003). Several
recent studies have implicated such immature monomeric SOD1
species as precursors in theALSmechanism (Furukawa et al., 2004;
Hough et al., 2004; Schmidlin et al., 2009). Reduced stability shifts
the folding equilibrium towards denatured monomers.
There are differences in the ability of amyloid conform-
ers with different SOD1 mutations to cross-seed with normal
SOD1 (Chia et al., 2010; Hwang et al., 2010). Using the altered
free energy of the denatured monomer of SOD1 species with
different mutations as an index, we examined whether the
prognostic role of prion-like propagation can explain the vari-
ance in survival times among patients with different SOD1
mutations.
CHANGES IN THE STABILITY OF SOD1 MUTANT PROTEINS
Native SOD1 is an extremely stable, obligate homodimer. A key
event in SOD1-linked ALS seems to be the pathological forma-
tion of toxic species of misfolded SOD1 as a result of initially
unfolded SOD1 mutants. Dimeric apoSOD1pWT (metal depleted,
pseudo-WT SOD1 with Cys-to-Ala substitutions at positions 6
and 111) has been shown to exhibit three-state folding behavior
in which the monomer folds independently following a classi-
cal two-state process (Lindberg et al., 2004). After folding, the
structured monomers assemble as homo-dimers according to the
relationship,
2D 2M M2,
where D is the unfolded monomer, M is the folded monomer, and
M2 is the dimer. Equilibrium studies tell us about the difference in
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free energy between the folded and the denatured state. Using the
stopped-ﬂow technique, Lindberg et al. (2004, 2005) reported the
effect of protein destabilization (G) upon ALS-associated point
mutations in SOD1 (Byström et al., 2010). Using these date, we
performed a regression analysis on the relationship between mean
age at disease onset (or respiratory failure death) in patients with
different point mutations and the effects of each point mutation
on protein destabilization, applying a mathematical model that
assumes that toxic species of the misfolded SOD1 are formed via
on-pathway nucleation-dependent polymerization:
Dimer  Unfolded monomer  Nucleus → Fibril
The clinical data used in this study and protein stability changes
(G) for each SOD1 mutation are summarized in Supplemen-
tal Table 1. Protein stability changes (G) were normalized for
comparison purposes.
MATHEMATICAL MODEL OF THE PROTECTIVE-AGGREGATION
HYPOTHESIS BASED ON NUCLEATION-DEPENDENT POLYMERIZATION
An exponential relationship would be expected to hold between
the effect of protein destabilization (G) and the nucleation lag
time of SOD1 aggregation, similar to the relationship between
polyQ length and nucleation lag time of polyQ aggregation (Sug-
aya and Matsubara, 2009, 2012). If the nucleation rate over time
acts as a constant risk for neuronal cell damage in a homogenous
cell population, the probability of aggregate-free neurons (or the
proportion of intact neurons) as a function of time t would be
expected to decline exponentially, consistent with the stochastic
appearance of nucleation. The rate constants for nucleation, esti-
mated by non-linear least-squares algorithms, are ∼10,000,000
times smaller than those for ﬁbril growth (Lee et al., 2007). There-
fore, under the assumption that toxic species of misfolded SOD1
are formed via on-pathway nucleation-dependent polymerization,
the proportion of intact neurons at time t is largely determined
by two integral elements: one reﬂects the probability distribution
function for nucleation lag time (tN), and the other corresponds
to an extension time (tE), reﬂecting the protective effects of aggre-
gate growth attributable to the decreased risk of neuronal cell loss.
Their relationships can be described by t2 = tN2 + tE2 in a linear
regressionmodel.We initiallymade the assumption that the extent
of motor neuron loss at the site of onset would be nearly identical
at disease onset regardless of the nature of the SOD1 mutation.
Then, mean age at onset (tA) can be expressed as a function of
protein stability change (x):
(mean tA
2 − t EA2 )1/2 = t NA = f (x) (1)
where tEA is tE at disease onset, tNA is tN at disease onset, and
f(x) is the integration of the probability distribution function of
nucleation lag time at disease onset as an exponential function of
the change in protein stability. Similarly, mean age at respiratory
failure death (tR) can be expressed as
(mean tR
2 − tER2)1/2 = tNR = g (x) (2)
where tER is tE at respiratory failure death, tNR is tN at respiratory
failure death, and g(x) is the integration of the probability
distribution function of nucleation lag time at respiratory failure
death as an exponential function of the change in protein stability
(x). Therefore, mean survival time among subjects with different
SOD1 mutations can be expressed as a function of protein stability
change as
mean t R − mean t A = (t ER2 + [g (x)]2)1/2−(t EA2 + [f (x)]2)1/2
(3)
We employed linear regression with logarithmic transformation
of Eqs 1 and 2, thus invoking an intrinsically linear model. Lin-
ear regression analysis was then applied to determine tE values
by identifying the points at which R2 values were identical for
a quadratic curve and a linear model that best ﬁt a linear rela-
tionship. Models were evaluated using R2 values, the F-test, and
analyses of residual error to test whether the assumptions of the
regression were reasonably satisﬁed.
PRION-LIKE PROPAGATION IS REFLECTED IN VARIABILITY OF SURVIVAL
TIME
The relationship between mean age at onset in patients with
different SOD1 mutations and changes in the stability of their
SOD1 mutant proteins showed a good ﬁt with a linear regres-
sion model of logarithmically transformed Eq. 1 (R2 = 0.85,
F = 126.0) when tEA2 = 140 (Figure 3A). The variability of
age at onset is well ﬁt by the model when the values of tEA2
are identical as expected by an exponential decline of neuronal
cell loss. Accordingly, the alternative role of prion-like propaga-
tion, together with Eq. 3, suggests that the variability in mean
survival time among patients with different SOD1 mutations is
largely dependent on the differences in extension time at respira-
tory failure death (tER). The concentration of unfolded mutant
SOD1 monomers varies according to the efﬁcacy of the cross-
seed reaction between the SOD1 aggregated form and normal
SOD1. Because the nucleation process is concentration depen-
dent, this alters the probability of nucleation and subsequent
generation of toxic species of misfolded SOD1, leading to the vari-
able values of tE2 (extension time due to the protective effects
of aggregate growth versus toxic species of misfolded SOD1)
from short survival to long survival. We ﬁrst considered that
the values of tER are nearly identical in subjects with SOD1
mutations that show a mean survival time less than 2.5 years,
and determined tER value using the regression model of loga-
rithmically transformed Eq. 2 to provide the best ﬁt to a linear
model. In a similar way, we next determined each value of tER in
patients with different SOD1 mutations. The relationship between
mean age at respiratory failure death in patients with different
SOD1 mutations and changes in the stability of their mutant
SOD1 proteins showed a good ﬁt with a linear regression model
of logarithmically transformed Eq. 2 (R2 = 0.93, F = 172.1)
for the variable tER2 values shown in Supplementary Table 1
(Figure 3B). Remarkably, the values of tER2 accounted for 84%
of the variability of mean survival time in patients with differ-
ent SOD1 mutations (Figure 3C). However, the values of tER2
showed no signiﬁcant correlation with the aggregation propen-
sity of individual SOD1 mutants (Vassall et al., 2011). Although
data are available for only a limited number of SOD1 mutants
(Chia et al., 2010; Hwang et al., 2010), the results appear to
Frontiers in Cellular Neuroscience www.frontiersin.org October 2014 | Volume 8 | Article 359 | 6
Sugaya and Nakano Prognostic role of prion-like propagation
FIGURE 3 | Changes in the stability of SOD1 proteins and phenotypic
variability of SOD1-linked FALS. (A) Correlation between mean age at onset
among patients with different SOD1 mutations and changes in the stability of
mutant SOD1 protein. A linear regression analysis using a logarithmic
transformation of Eq. 1 provided the best ﬁt to a linear model when
tEA
2 = 140. The tEA2 value was determined by identifying the points at
which R2 values were identical for a quadratic curve and a linear model.
(B) Correlation between mean age at respiratory failure death among patients
with different SOD1 mutations and changes in the stability of mutant SOD1
protein. A linear regression analysis using a logarithmic transformation of
Eq. 2 provided the best ﬁt to a linear model when the values of tER
2 were as
shown in Supplementary Table 1 (variable values of tER
2). Each value of
tER
2 was determined by identifying the point at which the R2 value was
identical for a quadratic curve and a linear model. (C) Correlation between the
values of tER
2 from the result of (B) and mean survival time among patients
with different SOD1 mutations.
be consistent with differences in the ability of SOD1 amyloid
conformers with different mutations to cross-seed with normal
SOD1.
DISCUSSION
In inherited neurodegenerative disorders, delayed clinical onset,
in which symptoms may not appear for years or decades, is often
assumed to reﬂect the occurrence of age-dependent cumulative
damage. One prediction of the cumulative-damage hypothesis
is that the probability of cell death will increase over time, and
the kinetics of neuronal death over time can be expressed by a
sigmoidal function. However, Clarke et al. (2000) reported that
the kinetics of neuronal loss in many forms of neurodegener-
ation appeared to be exponential, and in fact could be better
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explained by a mathematical model in which the risk of cell death
remains constant (one-hit model). The exponential decimation
of remaining lower motor neurons over time in ALS patients
is also consistent with the one-hit model of neurodegeneration
(Baumann et al., 2010, 2012). Furthermore, Clarke and Lums-
den (2005) showed that the one-hit model of neurodegeneration
can be improved using stretched exponential decay models, which
most easily ﬁt data in which the rate of death decreases over
time, consistent with multiple populations of neurons coexist-
ing, each with a different constant risk of death. However, there
are some scenarios in which it may also be possible to explain
such kinetics as an exponentially decreasing risk of neurodegen-
eration. For example, if dying neurons released a cyto-protective
substance such as a neurotrophic factor into their environment,
then the concentration of that factor would increase as more neu-
rons were affected, causing a concomitant decline in the risk of
cell death. One scenario has also emerged in the context of the
protective-aggregation hypothesis in which toxic species of mis-
folded proteins, as soluble oligomers, are formed as an on-pathway
intermediate innucleation-dependent polymerization. The expec-
tation under this scenario is that the kinetics of cell death would
reveal an exponentially decreasing risk, with further ﬁbril elonga-
tion reducing the risk posed by soluble oligomers in proportion
to the increased extent of aggregates. These scenarios suggest that,
although initiation of the neurodegenerative process occurs ran-
domly in time as a series of independent events for each neuron,
under the condition of exponentially decreasing risk, the progres-
sion of the neurodegenerative process may be inﬂuenced by other
cells.
One major unresolved question regarding the molecular mech-
anism underlying neurodegenerative process in patients with
SOD1-linked FALS is why the prognoses are so varied despite
a pathogenic mechanism in common. The duration of illness
is relatively consistent for each SOD1 mutation, but is variable
among different mutations. Wang et al. (2008) reported that two
synergistic properties, increased protein aggregation propensity
and decreased protein stability, account for 69% of the variabil-
ity in mutant Cu/Zn-superoxide-dismutase-linked familial ALS
patient survival times (Wang et al., 2008). However, in their regres-
sion analysis, about half of the patients had A4V mutation. Its
corrected value account for about 20% of the variability in sur-
vival times among subjects with different mutation. Recently,
Vassall et al. (2011) reported that in their depth analyses, there
is minimal to no correlation between observed aggregation, pre-
dicted aggregation propensity, and disease duration. Thus, the
major factor, which contributes to the disease progression, is still
unknown. The correlation between polyglutamine repeat length
and the effects of repeat length on the rate of disease progres-
sion, as well as age of onset, were well explained by the regression
models of Eqs 1 and 2 when polyglutamine repeat length was
used as an index (x; Sugaya and Matsubara, 2009, 2012). How-
ever, one distinct feature in the results of SOD1-linked FALS
stands out: the extension time (tE) is nearly identical among
subjects with different polyglutamine repeat-length, even those
with late-stage HD (Sugaya and Matsubara, 2012). Compared
with the mechanisms of prion-like propagation in SOD1 aggre-
gates, one clear difference is that mutant huntingtin aggregates
do not cross-seed in vitro with huntingtin containing normal
lengths of polyglutamine tracts (Busch et al., 2003). These features
support the idea that differences in the ability of SOD1 amyloid
conformers with different mutations to cross-seed with normal
SOD1 is reﬂected in the variability of survival time. These ﬁnd-
ings, together with the results of Figure 3 suggest the prognostic
value of prion-like propagation under the protective-aggregation
hypothesis, showing that it may account for up to 84% of the
variability in survival times across subjects with different SOD1
mutations.
CONCLUSION
At ﬁrst glance, several major aspects of the pathogenesis of SOD1-
linkedALS, including cell-autonomous and non-cell-autonomous
processes, prion-like propagation and exacerbation of disease
phenotypes in transgenic mice expressing both WT and mutant
SOD1, appear to be independent events, like pieces of a puzzle.
Viewed in the context of the protective-aggregation hypothesis,
the molecular events in prion propagation raise the possibility of
“prion-like propagation,” providing an alternative disease model
to account for the mechanism of SOD1-linked ALS. Consider-
able work remains to verify this disease model; however, a central
issue for future studies is connecting the factors involved in the
pathogenesis of SOD1-linked FALS with each other to delineate
the prognosis and spread of the disease.
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